Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2010 | 06-2010 | 03-2010 | 12-2009 | 09-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,520 | 7,310 | 14,150 | 14,070 | 22,020 |
| Other current assets | 550 | 700 | 850 | 750 | 1,360 |
| TOTAL | $7,070 | $8,010 | $15,000 | $14,820 | $23,380 |
| Non-Current Assets | |||||
| PPE Net | 1,510 | 1,510 | 1,510 | 1,510 | 1,500 |
| Other Non-Current Assets | 490 | 510 | 570 | 600 | 670 |
| TOTAL | $2,000 | $2,020 | $2,080 | $2,110 | $2,170 |
| Total Assets | $7,680 | $8,660 | $15,730 | $15,610 | $24,260 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 420 | 910 | 1,830 | 1,180 | 930 |
| Accrued Expenses | 3,120 | 3,910 | 5,300 | 6,430 | 7,000 |
| Other current liabilities | 2,590 | 5,010 | 3,500 | 850 | 0 |
| TOTAL | $6,150 | $9,840 | $10,640 | $8,460 | $7,930 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 9,080 | 1,820 | 10,860 | 1,350 | 3,360 |
| TOTAL | $9,080 | $1,820 | $10,860 | $1,350 | $3,360 |
| Total Liabilities | $15,230 | $11,660 | $21,500 | $9,810 | $11,290 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 449 | N/A | N/A | N/A | N/A |
| Common Shares | 970 | 690 | 690 | 620 | 620 |
| Retained earnings | -205,950 | -192,420 | -194,950 | -183,930 | -176,500 |
| Other shareholders' equity | 0 | 10 | 10 | 0 | 10 |
| TOTAL | $-7,550 | $-2,990 | $-5,770 | $5,790 | $12,970 |
| Total Liabilities And Equity | $7,680 | $8,670 | $15,730 | $15,600 | $24,260 |